Robert K. Bressin
Affiliations: | Chemistry | University of Pittsburgh, Pittsburgh, PA, United States |
Google:
"Robert Bressin"Mean distance: 8.56 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Beard JP, Bressin RK, Markaj PL, et al. (2023) Synthesis and Conformational Analysis of FR901464-Based RNA Splicing Modulators and Their Synergism in Drug-Resistant Cancers. Journal of Medicinal Chemistry. 66: 14497-14512 |
| Bressin RK, Osman S, Pohorilets I, et al. (2020) Total synthesis of meayamycin B. The Journal of Organic Chemistry |
| Bressin RK, Driscoll JL, Wang Y, et al. (2019) Scalable Preparation of Methylated Ando-Type Horner–Wadsworth–Emmons Reagent Organic Process Research & Development. 23: 274-277 |
| Wojtuszkiewicz A, Sciarrillo R, Jansen G, et al. (2016) Abstract 4336: Spliceosome inhibition as a novel therapeutic option in acute leukemia Cancer Research. 76: 4336-4336 |
| Schreiber CA, Sakuma T, Izumiya Y, et al. (2015) An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. Plos Pathogens. 11: e1005082 |
| Schreiber C, Sakuma T, Izumiya Y, et al. (2015) 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction Molecular Therapy. 23: S18 |
| Wojtuszkiewicz A, Assaraf YG, Jansen G, et al. (2014) Spliceosome Inhibitor Meayamycin B As a Novel Potential Chemotherapeutic Agent in ALL and AML Blood. 124: 924-924 |
| Knight S, Bressin RK, Basu U, et al. (2014) Inhibition of Splicing Factor SF3B1: Evaluating Effects on Iron Metabolism in K562 and CD34+ Cells Blood. 124: 1348-1348 |